Evaluation of the effect of curcumin in patients with cardiovascular diseases
Phase 2
- Conditions
- Coronary Artery Disease.Atherosclerotic heart disease of native coronary arteryI25.1
- Registration Number
- IRCT20230510058144N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients with coronary artery disease, who have at least one artery more than 70% blocked and confirmed by the cardiologist.
Patients are willing to participate in the study
Exclusion Criteria
Smoking
Continuous use of any antioxidant supplements such as vitamin E, vitamin C and selenium in the last month
Cancer
Existence of any change in the disease treatment plan, such as a change in the type and dose of lipid-lowering drugs or surgery
Unwillingness to cooperate in the study
The presence of advanced kidney disease
Autoimmune and infectious diseases
Pregnancy and breastfeeding
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method